Clinical Trial Update: A Study of the Effectiveness of Additional Risk Minimization Measures Related to ARAVA® (Leflunomide) in Saudi Arabia

View source ↗

Summary

A regulatory study assessing the effectiveness of additional risk minimization measures for ARAVA (Leflunomide) in Saudi Arabia. It focuses on safety improvemen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis
• Rheumatoid Arthritis

Drugs mentioned

• ARAVA (leflunomide)

Snippet

Sponsor: Sanofi | Conditions: Rheumatoid Arthritis, Psoriatic Arthritis | Status: ACTIVE_NOT_RECRUITING